This is a list of aircraft in alphabetical order beginning with 'Sd'.
Lists of aircraft |
---|
List of gliders |
---|
By constructor name |
(SDB, an enterprise of the Moscow State Technical University of Civil Aviation, Moscow, Russia)
SDB or sdb may refer to:
The GBU-53/B StormBreaker, previously known as the Small Diameter Bomb II, is an American air-launched, precision-guided glide bomb.
The GBU-39/B Small Diameter Bomb (SDB) is a 250-pound (110 kg) precision-guided glide bomb that is intended to allow aircraft to carry a greater number of smaller, more accurate bombs. Most US Air Force aircraft will be able to carry a pack of four SDBs in place of a single 2,000-pound (910 kg) Mark 84 bomb. It first entered service in 2006. The Ground Launched Small Diameter Bomb (GLSDB) was later developed to enable the SDB to be launched from a variety of ground launchers and configurations.
SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors, with an EC50 of 19 nM for human CB2 receptors, and 134 nM for human CB1 receptors. It was discovered during research into the related compound SDB-001 which had been sold illicitly as "2NE1". SDB-006 metabolism has been described in literature.
The SDB Karat is a Russian ultralight trike that was designed and produced by SDB of Moscow. The aircraft was supplied as a complete ready-to-fly-aircraft.
5F-SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors, with an EC50 of 50 nM for human CB1 receptors, and 123 nM for human CB2 receptors. It was discovered during research into the related compound APICA which had been sold illicitly as "2NE1". 5F-SDB-006 is the terminally fluorinated analog of SDB-006, just as STS-135 is the terminally fluorinated analog of APICA. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-SDB-006 may release benzylamine.
SDB-005 is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. It is presumed to be an agonist of the CB1 and CB2 cannabinoid receptors. SDB-005 is the indazole core analog of PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group.